Maybe ,,those who are more enlightened around gaap accounting standars would chime in to give some insight on tax implications. RVX with ruffly 300 million shares it might be expected that it would be worth at least  $1/share on a buy out. The buyer in essence would be getting the entire company for $000 dollars as an absolute perspective! So buying one ZENE indication might be what  kind of dollars verses  buying  the wholecompnay and RVX,,,it makes for an attractive asset overall one would think if we get some reliable data!

One other question,,back a few years, a news report out of Hong Kong from research doctors, I believe, used 3694 for CPC (Prostate Resistant Cancer) on a patient who had a miraculous recovery,, and being in stage 4 of this illness. They supposedly used AI to choose dosing etc. Does anyone remember this? I have done a ruff search with no luck but I do know it was a news worthy read back then!,,and a trigger to buy more stock!!!